Cellectis(FRA) ZVA

Market Cap€215.96M

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€2.83

-5.29%

-0.16Today

Cellectis Financials at a Glance

Market Cap

€215.96M

Revenue (TTM)

€48.46

Net Income (TTM)

-€56.06

EPS (TTM)

-€0.56

P/E Ratio

-5.35

Dividend

€0.00

Beta (Volatility)

-0.08 (Low)

Dividend

€0.00

Beta (Volatility)

-0.08 (Low)

Price

€2.83

Volume

Open

€2.83

Price

€2.83

Volume

Open

€2.83

Previous Close

€2.99

Daily Range

€2.83 - €2.83

52-Week Range

€2.19 - €4.66

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

-0.08 (Low)

Price

€2.83

Volume

Open

€2.83

Previous Close

€2.99

Daily Range

€2.83 - €2.83

52-Week Range

€2.19 - €4.66

Estimated Earnings Date

N/A

ZVA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cellectis

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.

Industry

Biotechnology

Sector

Health Care

Employees

229

CEO

André Choulika, PhD

Website

www.cellectis.com

ZVA Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-94.49%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-18.69%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€215.96M

Shares Outstanding

72.33M

Volume

Avg. Volume

29.864

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Cellectis Performance Analysis

Cellectis annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 18,241,169	-29.0%
2023	2023-12-31	EUR 698,353	-96.2%
2024	2024-12-31	EUR 38,370,486	5394.4%
2025	2025-12-31	EUR 64,637,981	68.5%

Cellectis annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -2.22	2.9%
2023	2023-12-31	EUR -1.64	-26.1%
2024	2024-12-31	EUR -0.38	-77.1%
2025	2025-12-31	EUR -0.60	59.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€4.50

+0.3%

Gross Profit

€0.70

+0.1%

Gross Margin

15.62%

+0.2%

Market Cap

€215.96M

N/A

Market Cap/Employee

€0.76

N/A

Employees

229

N/A

Net Income

-€18.77

+0.9%

EBITDA

-€18.12

+3.2%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€122.48

-17.2%

Total Debt

€91.21

+0.9%

Accounts Receivable

€4.44

+0.6%

Inventory

€0.00

N/A

Long Term Debt

€78.73

+1.0%

Short Term Debt

€12.48

+0.6%

Return on Assets

-20.94%

+1.3%

Return on Invested Capital

-40.32%

+1.1%

Free Cash Flow

-€12.57

+1.4%

Operating Cash Flow

-€12.36

+1.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About ZVA

What is the current price of Cellectis?

Cellectis is trading at €2.83 per share.

What is the 52-week range for Cellectis?

Over the past 52 weeks, Cellectis has traded between €2.19 and €4.66.

How much debt does Cellectis have?

As of the most recent reporting period, Cellectis reported total debt of €91.21M.

How much cash does Cellectis have on hand?

Cellectis reported €31.27M in cash and cash equivalents in its most recent financial results.

What is Cellectis’s dividend yield?

Cellectis does not currently have a dividend yield.

Cellectis(FRA) ZVA

Cellectis Financials at a Glance

ZVA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cellectis

ZVA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cellectis Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ZVA

What is the current price of Cellectis?

What is the 52-week range for Cellectis?

How much debt does Cellectis have?

How much cash does Cellectis have on hand?

What is Cellectis’s dividend yield?

Premium Investing Services